Spotlight on Research

Dr. Michael Gordon

Michael Gordon


For over 50 years, researchers at FRI have received federal, state, county, and private funding to conduct studies in the fields of substance abuse, health, HIV/AIDS, mental health, and criminal justice. Recent research has focused on the development and assessment of innovative strategies in pharmacotherapy, psychosocial treatments, biobehavioral HIV interventions, and prevention. Research at FRI is conducted by an interdisciplinary group of social scientists, whose work has garnered widespread recognition resulting from its contribution to both scientific knowledge and clinical practice. Presently, research studies and clinical trials are being conducted by FRI investigators both within the U.S. and throughout other parts of the world. Throughout its history and into the future, FRI is committed to contributing to the well-being of society through studies designed to alleviate health and social problems facing communities.


FRI has provided education and outpatient substance abuse counseling services for adolescents and adults for over 35 years in Baltimore County, Maryland, through Epoch Counseling Center. These services have been funded through federal, state, and county grants and contracts. FRI operates four centers and serves community residents through a variety of services. In addition to individual, group and family counseling, FRI offers state-certified DUI/DWI education and treatment programs, on-site drug screening, substance abuse evaluations, educational presentations, HIV testing and counseling, and support groups for family and friends. FRI is currently expanding its services for specific populations to include buprenorphine administration, anger management services, trauma care, and treatment for clients with co-occurring disorders.

Grants Administration

By managing all of the functions of grants administration, beginning with the pre-award process through completion of the research project, FRI allows scientists to focus on their research. This division of labor relieves the researchers of the necessary, but extremely time-consuming, work of grants management and allows them to concentrate on their work. FRI’s sound management practices ensure that program objectives are met and that project funds are disbursed in accordance with regulations. FRI’s successful history of grants management has always depended on its ability to build and maintain productive and respectful professional relationships with investigators and by offering a multitude of administrative services to support their research objectives.

Researcher Profiles
  • Robert P. Schwartz, M.D., FRI’s Medical Director, is an addiction psychiatrist and former Director of the Division of Alcohol and Drug Abuse ...  More
  • Frank J. Vocci, Ph.D., FRI’s President and Senior Research Scientist, spent 11 years at the FDA, rising to the level of Chief of the Drug Abuse Staff ...  More
  • Jerome H. Jaffe, M.D. is Clinical Professor of Psychiatry in the Division of Alcohol and Drug Abuse, University of Maryland School of Medicine,...  More
  • Cathy J. Reback, Ph.D. focuses on the intersection of HIV risk behaviors, substance use, sexual identity and gender identity.  More
  • Steven B. Carswell, Ph.D. focuses on community and environmental factors and their relationship to the incidence and prevalence of youth and adult...  More
  • Michael S. Gordon, D.P.A. conducts substance abuse and HIV research with criminal justice populations. Dr. Gordon’s research is focused on drug abuse ... More
  • Shannon Gwin Mitchell, Ph.D. is a Community Psychologist specializing in health promotion and disease prevention research ... More
  • Sharon M. Kelly, Ph.D. investigates ways of improving substance abuse treatment services, implementation, and delivery for opioid-dependent individuals. More
  • Dr. Gryczynski came to FRI in 2006 as a research assistant to work on disease prevention issues in American Indian communities...  More
News and Announcements
  • Dr. Cathy Reback Receives Award FRI is pleased to announce that Dr. Cathy Reback was recently awarded the Women in Leadership Award by the West Hollywood Women’s Advisory Board and the West Hollywood Chamber of Commerce for her work with gay/bisexual men and transgender women living with or at risk of acquiring HIV. Dr. Reback was presented the award at the 21st Annual Women in Leadership Awards ceremony on March 23, 2016. [ More ]

  • FRI Welcomes APRL Friends Research Institute is pleased to announce that the Addiction & Pharmacology Research Laboratory (APRL) under the leadership of Drs. John Mendelson and Gantt Galloway has recently joined FRI. The Addiction & Pharmacology Research Laboratory uses the tools of psychology, pharmacology, and cognitive science to understand the impact of non-medical drug use and to find better treatments for addiction. It develops innovative methods for conducting clinical trials and measuring the effects of drugs on the mind and body. Its research is funded by the National Institutes of Health, private industry, and generous donors.  FRI welcomes Dr. Mendelson, Dr. Galloway, and their research staff.

  • 2014 FRI AwardsFRI recently held its biennial Awards Reception at the Ritz-Carlton Residences, Inner Harbor in Baltimore.  During the reception several awards were presented to successful nominees.
    [ More ]

  • The connection between New Year's resolutions and a landmark study regarding heroin addiction among returning Vietnam War veterans. Jerome JaffeRead a 2012 NPR article that refers to FRI Senior Research Scientist, Dr. Jerome Jaffe, about a connection between New Year’s Resolutions and the landmark study about heroin addiction among returning Vietnam War veterans commissioned by Dr. Jaffe and led by the late Dr. Lee Robins.
    [ What Vietnam Taught Us About Breaking Bad Habits ]

  • FRI Named Top Workplace 2014 Top Workplace 2014Friends Research Institute was recently named to the list of “The Baltimore Sun Top Workplaces” for 2014. FRI is honored to be included for a fourth year in a row and to work with such a great group of employees!
    [ More ]

  • FRI Named Top Workplace 2013 Top Workplace 2013Friends Research Institute was recently named to the list of “The Baltimore Sun Top Workplaces” for 2013. This is FRI’s third year in a row for making the list.
    [ More ]

  • COG Analytics Website Debut
    FRI is pleased to announce the debut of the COG Analytics website, indicated on the FRI homepage by a new tab. Founded in 2012, through a partnership with FRI, COG Analytics is a research and technology company committed to identifying and addressing the social and environmental determinants that contribute to poor health outcomes. The company’s focus is on the development of technologies that are designed to promote healthy behaviors.
    [ More ]

  • Dr. Frank Vocci Delivers Annual Andrew G. DuMez Memorial Lecture Frank VocciFrank J. Vocci, President and Senior Research Scientist at FRI, delivered the annual Lecture at the University of Maryland School of Pharmacy on April 8, 2013.
    [ More ]

  • FRI Named Top Workplace 2012 Top Workplace 2012Friends Research Institute was recently named to the list of “The Baltimore Sun Top Workplaces” for 2012. FRI had a high survey response rate from its employees.
    [ More ]

  • New Senior Research Scientist Joins FRI Jami OberMayerDr. Jami Obermayer, formerly the Director of Research at PICS, Inc., has accepted a position as a Senior Research Scientist at FRI.
    [ More ]

  • New Research Scientist Joins FRI Dr. PetersDr. Peters is a clinical psychologist specializing in treatment efficacy, human laboratory, and natural history studies for marijuana and tobacco cessation.
    [ More ]

  • FRI President Joins Journal of Addiction Medicine Frank VocciDr. Frank Vocci has been named as the third Co-Editor of Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine (ASAM).
    [ More ]

  • FRI employee, Jan Gryczynski, Awarded Doctoral Degree Jan GryczynskiJan Gryczynski, Research Scientist at FRI, recently received his Ph.D. in Public Policy from the University of Maryland, Baltimore County.
    [ More ]

  • FRI is pleased to welcome Dr. Melicia Whitt-Glover as an Affiliated Senior Research Scientist. Melicia Whitt-GloverDr. Whitt-Glover is President and CEO of Gramercy Research Group in Winston-Salem, North Carolina.
    [ More ]

  • FRI Named Top Workplace 2011 Top WorkplaceFriends Research Institute was recently named to the list of “The Baltimore Sun Top Workplaces” for 2011. FRI had a high survey response rate from its employees.
    [ More ]

  • Medical Director Robert Schwartz presented research findings in Russia. [ More ]

  • Dr. Robert Schwartz Invited to Serve on Editorial Board of the Journal of Substance Abuse Treatment (JSAT) [ More ]

  • Dr. Robert Schwartz Invited to Serve As IAS-NIDA Fellowship Mentor for prospective fellows in the 2012 Round. [ More ]
Recent Publications
  • In Press Gordon, M.S., Carswell, S.B., Peters, E.N., Tangires, S., Kinlock, T.W., Vocci, F.J., & Restivo, L. (in press). Avatar assisted therapy: A novel technology-based Intervention to treat substance use disorders. In Pam Lassiter (ed.), Annual Review of Addictions and Offender Counseling: Best Practices III (p x-x). Eugene, OR: Wipf & Stock Publishers [More]
  • Gryczynski, J., Schwartz, R. P., O’Grady, K. E., Restivo, L., Mitchell, S. G., & Jaffe, J. H. (in press). People with substance use disorders for illicit drugs other than alcohol or marijuana have elevated hospitalization rates. Health Affairs. [More]
  • Hernández D, Feaster DJ, Gooden L, Douaihy A, Mandler R, Erickson SJ, Kyle T, Haynes L, Schwartz R, Das M, Metsch L. (in press). Self-Reported HIV and HCV Screening Rates and Serostatus among Substance Abuse Treatment Patients. AIDS Behav. [More]
  • Nyamathi, A. M., Reback, C. J., Shoptaw, S., Salem, B. E., Zhang, S., Farabee, D., Khalilifard, F. (in press). Impact of Community-Based Programs on Incarceration Outcomes Among Gay and Bisexual Stimulant-Using Homeless Adults. Community Ment Health J. [More]
  • Nyamathi, A., Reback, C.J., Shoptaw, S., Salem, B.E., Zhang, S., Yadav, K. (in press). Impact of Tailored Interventions to Reduce Drug Use and Sexual Risk Behaviors Among Homeless Gay and Bisexual Men. Am J Mens Health. [More]
  • Young, S.D., Swendeman, D., Holloway, I.W., Reback, C.J., Kao, U. (in press). Use of Technology to Address Substance Use in the Context of HIV: A Systematic Review. Curr HIV/AIDS Rep. [More]
  • Reback, C.J., Ferlito, D., Kisler, K.A. & Fletcher, J.B. (in press). Recruiting, Linking, and Retaining High-risk Transgender Women into HIV Prevention and Care Services: An Overview of Barriers, Strategies, and Lessons Learned. International Journal of Transgenderism. DOI:10.1080/15532739.2015.1081085. [More]
  • Young, S.D., Swendeman, D., Holloway, I.W., Reback, C.J., Kao, U. (in press). Use of Technology to Address Substance Use in the Context of HIV: A Systematic Review. Curr HIV/AIDS Rep. [More]

  • 2016 Chandler, R.K., Finger, M.S., Farabee, D., Schwartz, R.P., Condon, T., Dunlap, L.J., Zarkin, G.A., McCollister, K., McDonald, R.D., Laska, E., Bennett, D., Kelly, S.M., Hillhouse, M., Mitchell, S.G., O'Grady, K.E., Lee, J.D. (2016). The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings. Contemp Clin Trials. 48:166-72. doi: 10.1016/j.cct.2016.05.003. PMID: 27180088.
  • Fletcher, J. B., and Reback, C. J. (2016). Mental health disorders among homeless, substance-dependent men who have sex with men. Drug and Alcohol Review, doi: 10.1111/dar.12446.
  • Glasner-Edwards, S., Patrick, K., Ybarra, M.L., Reback, C.J., Rawson, R.A., Garneau, H.C., Chavez, K. and Venegas, A. (2016). A Cognitive Behavioral Therapy Based Text Messaging Intervention Versus Medical Management for HIV-Infected Substance Users: Study Protocol for a Pilot Randomized Trial. JMIR research protocols. 5(2).
  • Gordon, M.S., Carswell, S.B., Wilson, M., Kinlock, T.W., Restivo, L., McKenzie, M., Rich, J.D. (2016). Factors Associated With Receiving Rapid HIV Testing Among Individuals on Probation or Parole. J Correct Health Care. 22(4):290-299. PMID: 27742854.
  • Gryczynski. J., O'Grady, K.E., Mitchell, S.G., Ondersma, S.J., Schwartz, R.P. (2016). Immediate Versus Delayed Computerized Brief Intervention for Illicit Drug Misuse. J Addict Med. 10(5):344-51. doi: 10.1097/ADM.0000000000000248. PMID: 27504925.
  • Gryczynski, J., Schwartz, R.P., O'Grady, K.E., Restivo, L., Mitchell, S.G., Jaffe, JH. (2016). Understanding Patterns Of High-Cost Health Care Use Across Different Substance User Groups. Health Aff (Millwood). 35(1):12-9. doi: 10.1377/hlthaff.2015.0618. PMID: 26733696.
  • Hong, Y. A., Mitchell, S. G., Peterson, J. A., Latkin, C., & Tobin, K. (2016). Ethnographic process evaluation. Monitoring and Evaluation in Health and Social Development: Interpretive and Ethnographic Perspectives, 159.
  • Hunter, S.B., Schwartz, R.P., Friedmann, P.D. (2016). Introduction to the Special Issue on the Studies on the Implementation of Integrated Models of Alcohol, Tobacco, and/or Drug Use Interventions and Medical Care. J Subst Abuse Treat. 60:1-5. doi: 10.1016/j.jsat.2015.10.001. Epub 2015 Oct 20. PMID: 26549295.
  • Kelly, S.M., Gryczynski, J., Mitchell, S.G., Kirk, A., O'Grady, K.E., Schwartz, R.P. (2016). Corrigendum to "Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients" [Drug Alcohol Depend. 140 (2014) 213-216]. Drug Alcohol Depend. 168:203. doi: 10.1016/j.drugalcdep.2016.09.012. PMID: 27697697.
  • Kinlock, T.W., & Gordon, M.S. (2016). Heroin and Other Opiates. In Henry H. Brownstein (ed.) The Handbook of Drugs and Society, (pp. 72-89). West Sussex, UK: John Wiley & Sons, Inc.
  • McNeely, J., Wu, L.T., Subramaniam, G., Sharma, G., Cathers, L.A., Svikis, D., Sleiter, L., Russell, L., Nordeck, C., Sharma, A., O'Grady, K.E., Bouk, L.B., Cushing, C., King, J., Wahle, A., Schwartz, R.P. (2016). Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Ann Intern Med. 165(10):690-699. doi: 10.7326/M16-0317. PMID: 27595276.
  • Mitchell, S.G., Schwartz, R.P., Kirk, A.S., Dusek, K., Oros, M., Hosler, C., Gryczynski, J., Barbosa, C., Dunlap, L., Lounsbury, D., O'Grady, K.E., Brown, B.S. (2016). SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers. J Subst Abuse Treat. 60:81-90. doi:10.1016/j.jsat.2015.06.011. Epub 2015 Jun 26. PMID: 26297321.
  • Mitchell, S. G., Willett, J., Monico, L. B., James, A., Rudes, D. S., Viglioni, J., Schwartz, R. P., Gordon, M. S., & Friedmann, P. D. (2016). Community Correctional Agents' Views of Medication-Assisted Treatment: Examining their Influence on Treatment Referrals and Community Supervision Practices. Substance Abuse. 37(1):127-33. doi: 10.1080/08897077.2015.1129389. PMID: 26860334. PMCID: PMC4823810.
  • Monico, L.B, Mitchell, S.G., Welsh, W., Link, N., Hamilton, L., Malvini, Redden, S., Schwartz, R.P., Friedmann, P.D. (2016). Developing effective interorganizational relationships between community corrections and community treatment providers. Journal of Offender Rehabilitation. 55(7):484-501.
  • Monico, L., Schwartz, R. P., Gryczynski, J., O'Grady, K. E., & Mitchell, S. G. (2016). Two models of integrating buprenorphine treatment and medical staff within formerly "drug-free" outpatient programs. Journal of Psychoactive Drugs. 48(2):101-8. doi: 10.1080/02791072.2015.1130884. PMID: 26940870.
  • O'Grady, K.E., Gryczynski, J., Mitchell, S.G., Ondersma, S.J., Schwartz, R.P. (2016). Confirmatory factor analysis of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in community health center patients. Am J Addict. 25(4):259-63. doi: 10.1111/ajad.12360. PMID: 27037633.
  • Ondersma, S.J., Gryczynski, J., Mitchell, S.G., O'Grady, K.E., Schwartz, R.P. (2016). Process evaluation of a technology-delivered screening and brief intervention for substance use in primary care. Internet Interventions. 4(Pt 1):11-16. PMID: 27110494PMCID: PMC4836054. DOI: 10.1016/j.invent.2016.01.004.
  • Pines, H. A., Gorbach, P. M., Weiss, R. E., Reback, C. J., Landovitz, R. J., Mutchler, M. G., & Mitsuyasu, R. T. (2016). Individual-Level, Partnership-Level, and Sexual Event-Level Predictors of Condom Use During Receptive Anal Intercourse Among HIV-Negative Men Who Have Sex with Men in Los Angeles. AIDS and Behavior. 20(6), 1315-1326.
  • Reback, C. J., Kaplan, R. L., Bettcher, T. M., & Larkins, S. (2016). The role of the illusion in the construction of erotic desire: narratives from heterosexual men who have occasional sex with transgender women. Culture, Health & Sexuality, 18(8), 951-963.
  • Rosenthal, R. N., Lofwall, M. R., Kim, S., Chen, M., Beebe, K. L., & Vocci, F. J. (2016). Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine: A randomized clinical trial. JAMA. 316(3), 282-290.
  • Rusow, J. A., Fletcher, J. B., & Reback, C. J. (2016). Sexual Venue Choice and Sexual Risk-Taking Among Substance-Using Men Who have Sex with Men. AIDS and Behavior, 1-14.
  • Schwartz, R.P. (2016). When Added to Opioid Agonist Treatment, Psychosocial Interventions do not Further Reduce the Use of Illicit Opioids: A Comment on Dugosh et al. J Addict Med. 10(4):283-5. doi: 10.1097/ADM.0000000000000236. PMID: 27471920.
  • Schwartz, R.P., Kelly, S.M., Mitchell, S.G., Dunlap, L., Zarkin, G.A., Sharma, A., O'Grady, K.E., Jaffe, J.H. (2016). Corrigendum to "Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial." [Contemp. Clin. Trials 49 (2016): 21-28]. Contemp Clin Trials. 51:97. doi: 10.1016/j.cct.2016.09.008. No abstract available. PMID: 27729206.
  • Schwartz, R.P., Kelly, S.M., Mitchell, S.G., Dunlap, L., Zarkin, G.A., Sharma, A., O'Grady, K.E., Jaffe, J.H. (2016). Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial. Contemp Clin Trials. 49:21-8. doi: 10.1016/j.cct.2016.06.002. PMID: 27282117.
  • Schwartz, R.P., Kelly, S.M., Mitchell, S.G., Gryczynski, J., O'Grady, K.E., Gandhi, D., Olsen, Y., Jaffe, J.H. (2016). Patient-centered methadone treatment: a randomized clinical trial. Addiction. doi: 10.1111/add.13622. [Epub ahead of print]. PMID: 27661788.
  • Serpelloni, G., Genetti, B., Andreotti, A., Sperotto, M., Zermiani, M., Sharma, A., O'Grady, K.E., Schwartz, R.P. (2016). Prevalence and correlates for alcohol, cigarette, and cannabis use among Italian high school students: a national survey. Substance Abuse and Rehabilitation.
  • Sharma, A., O'Grady, K.E., Kelly, S.M., Gryczynski, J., Mitchell, S.G., Schwartz, R.P. (2016). Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions. Subst Abuse Rehabil. 7:27-40. doi: 10.2147/SAR.S81602. Review. PMID: 27217808. PMCID: PMC4853155 DOI: 10.2147/SAR.S81602.
  • Sigmon, S.C., Ochalek, T.A., Meyer, A.C., Hruska, B., Heil, S.H., Badger, G.J., Rose, G., Brooklyn, J.R., Schwartz, R.P., Moore, B.A., Higgins, S.T. (2016). Interim Buprenorphine vs. Waiting List for Opioid Dependence. N Engl J Med. 375(25):2504-2505. doi: 10.1056/NEJMc1610047. No abstract available. PMID: 28002704. DOI: 10.1056/NEJMc1610047.
  • Wu, L.T., McNeely, J., Subramaniam, G., Sharma, G., VanVelduisen, P., Schwartz, R.P. (2016). Design of the NIDA Clinical Trials Network Validation Study of Tobacco, Alcohol, Prescription Medications, and Substance Use/Misuse (TAPS) Tool. Contemporary Clinical Trials, 50:90-7. doi: 10.1016/j.cct.2016.07.013. PMID: 27444426.
  • Wu, L.T., McNeely, J., Subramaniam, G.A., Sharma, G., VanVeldhuisen, P., Schwartz, R.P. (2016). Corrigendum to "Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool" [Contemporary Clinical Trials. 19; 50: 90-97]. Contemp Clin Trials, 51:98. doi: 10.1016/j.cct.2016.09.001. PMID: 27665683.

  • 2015 Barbosa, C., Dunlap, L. J., Wedehase, B., Mitchell, S. G., Schwartz, R. P., Dusek, K., Kirk, A.S., Oros, M., Hosler, C., Gryczynski, J., Brown, B. S. (2015). Start-up costs of implementing Screening and Brief Intervention (SBI) for Adolescents (part of Economics of SBI symposium). Addiction science & clinical practice, 10(Suppl 2), O5.
  • Fletcher, J.B., Reback, C.J. (2015). Depression Mediates and Moderates Effects of Methamphetamine Use on Sexual Risk Taking Among Treatment-Seeking Gay and Bisexual Men. Health Psychol. 34(8):865-9. doi: 10.1037/hea0000207. Epub 2015 Jan 12. PMID: 25581704.
  • Gordon, M.S., Kinlock, T.W., Schwartz, R.P., Couvillion, K.A., Sudec, L.J., O'Grady, K.E., Vocci, F.J., Shabazz, H. (2015). Buprenorphine Treatment for Probationers and Parolees. Subst Abus. 36(2):217-25. doi: 10.1080/08897077.2014.902787. Epub 2014 Apr 4. PMID: 24701967.
  • Gordon MS, Kinlock TW, Vocci FJ, Fitzgerald TT, Memisoglu A, Silverman B. (2015). A Phase 4, Pilot, Open-Label Study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for Prisoners. J Subst Abuse Treat. 59:52-8. doi: 10.1016/j.jsat.2015.07.005. Epub 2015 Jul 18. PMID: 26299956.
  • Gryczynski, J., Kelly, S.M., Mitchell, S.G., Kirk, A., O'Grady, K.E., Schwartz, R.P. (2015). Validation and performance of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) among adolescent primary care patients. Addiction. 110(2):240-7. doi: 10.1111/add.12767. Epub 2014 Nov 20. PMID: 25311148.
  • Gryczynski, J., Mitchell, S.G., Gonzales, A., Moseley, A., Peterson, T.R., Ondersma, S.J., O'Grady, K.E., Schwartz, R.P. (2015). A randomized trial of computerized vs. in-person brief intervention for illicit drug use in primary care: outcomes through 12 months. Journal of Substance Abuse Treatment. 50, 3-10. doi: 10.1016/j.jsat.2014.09.002. Epub 2014 Sep 16. PMID: 25282578.
  • Gryczynski, J., Mitchell, S.G., Jaffe, J. H., O'Grady K, E., Olsen Y. K., Schwartz R. P. (2015). Leaving buprenorphine treatment: patients' reasons for cessation of care. J Subst Abuse Treat, 46(3):356-61. PubMed PMID: 24238714; PubMed Central PMCID: PMC3947058.
  • Gryczynski, J., Mitchell, S.G., Ondersma, S.J., O'Grady, K.E., Schwartz, R.P. (2015). Potential radiating effects of misusing substances among medical patients receiving brief intervention. J Subst Abuse Treat. 55:39-44.
  • Gryczynski, J., Nordeck, C., Mitchell, S. G., O’Grady, K. E., McNeely, J., Wu, L.-T., & Schwartz, R. P. (2015). Reference periods in retrospective behavioral self-report: A qualitative investigation. American Journal on Addictions, 24(8): 744-747.
  • Gryczynski, J., Schwartz, R. P., Mitchell, S. G., Dzirasa, L., Dusek, K., O’Grady, K., & Cowell, A. (2015). Preliminary research in preparation for a randomized trial of brief intervention strategies for adolescents in school-based health centers. Addiction Science & Clinical Practice, 10(Suppl 2), O20.
  • Hall, T.M., Reback, C.J., & Shoptaw, S. (2015). Clinical Management of Substance Use and Substance Use Disorders among LGBT Individuals. In H.J. Makadon, K.H. Mayer, J. Potter, & H. Goldhammer (Eds.), The Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health, 2nd Edition. Philadelphia: American College of Physicians Books, pp. 227-267.
  • Kinlock, T.W., & Gordon, M.S., Shabazz, H. (2015). Pharmacotherapy for Incarcerated Individuals with Histories of Heroin Addiction. In Ayman M. Fareed (ed.), Heroin Addiction: Prevalence, Treatment Approaches and Health Consequences (pp. 127-142). Hauppauge, NY: Nova Science Publishers, Inc.
  • Landovitz, R.J., Fletcher, J.B., Shoptaw, S., Reback, C.J. (2015). Contingency management facilitates the use of postexposure prophylaxis among stimulant-using men who have sex with men. Open Forum Infect Dis. 1;2(1):ofu114. doi: 10.1093/ofid/ofu114. eCollection 2015 Jan. PMID: 25884003. PMCID: PMC4396429.
  • Lee, J.D., Friedmann, P.D., Boney, T.Y., Hoskinson, R. A Jr, McDonald, R., Gordon, M., Fishman, M., Chen, D.T., Bonnie, R.J., Kinlock, T.W., Nunes, E.V., Cornish, J.W., O'Brien, C.P. (2015). Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial. Contemp Clin Trials. 41:110-7.
  • Mitchell, S.G., Gryczynski, J., Schwartz, R.P., Myers, C.P., O'Grady, K.E., Olsen, Y.K., Jaffe, J.H. (2015). Changes in Quality of Life following Buprenorphine Treatment: Relationship with Treatment Retention and Illicit Opioid Use. J Psychoactive Drugs. 47(2):149-57.
  • Mitchell, S.G., Monico, L.B., Gryczynski, J., O'Grady, K.E., Schwartz, R.P. (2015). Staff Views of Acceptability and Appropriateness of a Computer-Delivered Brief Intervention for Moderate Drug and Alcohol Use. J Psychoactive Drugs. 47(4):301-7. doi: 10.1080/02791072.2015.1075631. Epub 2015 Sep 16. PMID: 26375411.
  • Mitchell, S.G., Schwartz, R.P., Alvanzo, A.A., Weisman, M.S., Kyle, T.L., Turrigiano, E.M., Gibson, M.L., Perez, L., McClure, E.A., Clingerman, S., Froias, A., Shandera, D.R., Walker, R., Babcock, D.L., Bailey, G.L., Miele, G.M., Kunkel, L.E., Norton, M., Stitzer, M.L. (2015). The Use of Technology in Participant Tracking and Study Retention: Lessons Learned from a Clinical Trials Network Study. Subst Abus. 36(4):420-6. doi: 10.1080/08897077.2014.992565. Epub 2015 Feb 11. PMID: 25671593. PMCID: PMC4532645.
  • Mitchell, S. G., Willett, J., Swan, H., Monico, L. B., Yang, Y., Patterson, Y., Belenko, S., Vega-Debien Graciela, Pankow, J., Schwartz, R. P. & Visher, C. (2015). Defining success: Insights from a random assignment, multi-site study of implementing HIV prevention, testing and linkage to care in US jails and prisons. AIDS Education and Prevention. 27(5):432-45. doi: 10.1521/aeap.2015.27.5.432. PMID: 26485233.
  • Monico, L.B., Gryczynski, J., Mitchell, S.G., Schwartz, R.P., O'Grady, K.E., Jaffe, J.H. (2015). Buprenorphine treatment and 12-step meeting attendance: conflicts, compatibilities, and patient outcomes. J Subst Abuse Treat. 57:89-95. doi: 10.1016/j.jsat.2015.05.005. Epub 2015 May 12. PMID: 25986647.
  • Monico, L.B., Mitchell, S.G., Gryczynski, J., Schwartz, R.P., O'Grady, K.E., Olsen, Y.K., Jaffe, J.H. (2015). Prior experience with non-prescribed buprenorphine: Role in treatment entry and retention. J Subst Abuse Treat. 57:57-62. doi: 10.1016/j.jsat.2015.04.010. Epub 2015 May 7. PMID: 25980599.
  • Nyamathi, A., Reback, C.J., Salem, B.E., Zhang, S., Shoptaw, S., Branson, C.M., Leake, B. (2015). Correlates of self-reported incarceration among homeless gay and bisexual stimulant-using young adults. West J Nurs Res. 37(6):799-811. doi: 10.1177/0193945914530521. Epub 2014 Apr 14. PMID: 24733231.
  • Peters, E.N., Harrell, P.T., Hendricks, P.S., O'Grady, K.E., Pickworth, W.B., Vocci, F.J. (2015). Electronic cigarettes in adults in outpatient substance use treatment: Awareness, perceptions, use, and reasons for use. Am J Addict. 24(3):233-9.
  • Peters, E.N., Nordeck, C., Zanetti, G., O'Grady, K.E., Serpelloni, G., Rimondo, C., Blanco, C., Welsh, C., Schwartz, R.P. (2015). Relationship of gambling with tobacco, alcohol, and illicit drug use among adolescents in the USA: Review of the literature 2000-2014. Am J Addict. 24(3):206-16.
  • Reback, C. J., Fletcher, J. B., Shoptaw, S., Mansergh, G. (2015). Exposure to Theory-Driven Text Messages is Associated with HIV Risk Reduction Among Methamphetamine-Using Men Who have Sex with Men. AIDS Behav. 19 Suppl 2:130-41. doi: 10.1007/s10461-014-0985-7. PMID: 25563501.
  • Reback CJ, Kaplan RL, Larkins S. (2015). Disclosure of Male Sexual Partnering and HIV Serostatus Among a Sample of Heterosexually Identified Men Who Have Sex With Men and Women. AIDS Educ Prev. 27(3):227-39. doi: 10.1521/aeap.2015.27.3.227. PMID: 26010314.
  • Salem, B., Nyamathi, A., & Reback, C.J. (2015). Unmet Physical and Mental Healthcare Needs among Stimulant-using Gay and Bisexual Homeless Men. Issues in Mental Health Nursing. 36: 685-692. DOI: 10.3109/01612840.2015.1021938.
  • Schwartz, R.P., Kelly, S.M., Gryczynski, J., Mitchell, S.G., O'Grady, K.E., Jaffe, J.H. (2015). Heroin use, HIV-risk, and criminal behavior in Baltimore: Findings from Clinical Research. J Addict Dis. 34(2-3):151-61. doi: 10.1080/10550887.2015.1059222. PMID: 26079104.
  • Sigmon, S.C., Meyer, A.C., Hruska, B., Ochalek, T., Rose, G., Badger, G.J., Brooklyn, J.R., Heil, S.H., Higgins, S.T., Moore, B.A., & Schwartz, R.P. (2015). Bridging waitlist delays with Interim Buprenorphine Treatment: Initial feasibility. Addictive Behaviors. 51:136-142.
  • Vocci, F.J., Schwartz, R.P., Wilson, M.E., Gordon, M.S., Kinlock, T.W., Fitzgerald, T.T., O'Grady, K.E., Jaffe, J.H. (2015). Buprenorphine dose induction in non-opioid-tolerant pre-release prisoners. Drug Alcohol Depend. 156:133-8. doi: 10.1016/j.drugalcdep.2015.09.001. Epub 2015 Sep 7. PMID: 26409751.

  • 2014 Behavioral Neurology Bellamoli, E., Manganotti, P., Schwartz, R. P., Rimondo, C., Gomma, M., Serpelloni, G. (2014). rTMS in the treatment of drug addiction: an update about human studies. [More]
  • Journal of Substance Abuse Treatment Fletcher, J.B., Dierst-Davies, R., Reback, C. J. (2014). Contingency management voucher redemption as an indicator of delayed gratification. [More]
  • Ment Health Subst Use Fletcher, J. B., Shoptaw, S., Peck, J.A., Reback, C. J. (2014). Contingency Management Reduces Symptoms of Psychological and Emotional Distress among Homeless, Substance-dependent Men Who Have Sex with Men. [More]
  • Journal of Substance Abuse Treatment Gryczynski, J., Mitchell, S.G., Jaffe, J. H., O'Grady K, E., Olsen Y. K., Schwartz R. P. (2014). Leaving buprenorphine treatment: patients' reasons for cessation of care. [More]
  • Drug and Alcohol Dependence Kelly, S. M., Gryczynski, J., Mitchell, S. G., Kirk, A., O'Grady, K. E., Schwartz, R. P. (2014). Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients. [More]
  • Pediatrics Kelly, S. M., Gryczynski, J., Mitchell, S. G., Kirk, A., O'Grady, K. E., Schwartz, R. P. (2014). Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use. [More]